| Grant and contract revenue | |
| Product sales | 6.85M |
| Total revenue | 6.85M |
| Cost of sales | 3.55M |
| Research and development | 3.6M |
| Sales, general, and administrative | 4.49M |
| Total costs and expenses | 11.64M |
| Loss from operations | -4.79M |
| Foreign exchange gain (loss) | |
| Interest expense | -877K |
| Interest income | |
| Total other income (expense) | -876K |
| NET LOSS | -5.67M |
| Net loss per common share - basic and diluted | -1.17 |
| Weighted average number of common shares outstanding - basic and diluted | |